Abstract: A selective shelf lighting system is provided. The shelf lighting system is adapted so that portions of the shelving may be selectively powered via a wireless computing device based on inventory associated with those portions, wherein the desired inventory may be identified by the wireless computing device is provided. The shelf lighting system is enabled so that one or more portions of light tracks connected to the shelving are powered so as to specifically identify a relevant portion of the shelf associated with an inventory item a user inputs into the wireless computing device. A systemic software application can associate each portion of the light track(s) with a predetermined inventory item so that a user of the wireless computing device, such as a customer or a stockperson, can identify the relevant location of possibly a vast array of shelves within a large storage space.

Abstract: A universal wireless computing system is provided. The wireless computing system includes two or more devices having a systemic software application loaded thereon. A host device rebroadcasting a third-party wireless signal so that similarly situated devices also having the systemic software application can access and a rebroadcast the wireless signal for other proximate similarly-situated devices to access and rebroadcast.

Abstract: The present invention relates generally to methods for treating injury or degeneration of retinal neurons, and in particular photoreceptors, by administering glial cell line-derived neurotrophic factor (GDNF). The invention relates specifically to methods for treating retinal conditions or diseases in which vision is lost such as retinitis pigmentosa, age-related macular degeneration, diabetic retinopathy, peripheral vitreoretinopathies, photic retinopathies, surgery-induced retinopathies, viral retinopathies, ischemic retinopathies, retinal detachment and traumatic retinopathy.

Abstract: The present invention relates generally to methods for treating injury or degeneration of retinal ganglion cells by administering glial cell line-derived neurotrophic factor (GDNF). The invention relates specifically to methods for treating optic nerve injury or degeneration associated with glaucoma.

Abstract: The present invention relates generally to methods for treating injury or degeneration of retinal neurons, and in particular photoreceptors, by administering glial cell line-derived neurotrophic factor (GDNF). The invention relates specifically to methods for treating retinal conditions or diseases in which vision is lost such as retinitis pigmentosa, age-related macular degeneration, diabetic retinopathy, peripheral vitreoretinopathies, photic retinopathies, surgery-induced retinopathies, viral retinopathies, ischemic retinopathies, retinal detachment and traumatic retinopathy.